SB-258585 dihydrochloride, >=98% (HPLC), powder
Biochem/physiol Actions
5-HT6 serotonin receptor antagonist.
Features and Benefits
This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Legal Information
Sold for research purposes under agreement from GlaxoSmithKline
Packaging
10, 50 mg in glass bottle
| Colour | white to beige |
|---|---|
| Quality Level | 100 |
| InChI key | QDYGVTFRTVLFCD-UHFFFAOYSA-N |
| InChI | 1S/C18H22IN3O3S.2ClH/c1-21-9-11-22(12-10-21)17-13-15(5-8-18(17)25-2)20-26(23,24)16-6-3-14(19)4-7-16;;/h3-8,13,20H,9-12H2,1-2H3;2*1H |
| Manufacturer | SIGMA-ALDRICH |
| Further Info | Store under nitrogen; package with desiccants at 4°C |
| Form | powder |
| Assay | ≥98% (HPLC) |
There are no downloads for this product.
